A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants
Clinical trial NCT06435923 · COMPLETED
Trial details
- NCT number
- NCT06435923
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2024-07-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.